Jacobs Levy Equity Management
ETNB

Jacobs Levy Equity Management’s 89bio ETNB Stock Holding History

Jacobs Levy Equity Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-98,848
Closed -$719K – 1075
2025
Q1 		$719K Buy
+98,848
New +$864K ﹤0.01% 868
2024
Q4 		– Sell
-130,894
Closed -$969K – 972
2024
Q3 		$969K Buy
130,894
+85,230
+187% +$717K ﹤0.01% 726
2024
Q2 		$366K Buy
+45,664
New +$408K ﹤0.01% 872
2021
Q1 		– Sell
-9,784
Closed -$238K – 1050
2020
Q4 		$238K Sell
9,784
-585
-6% -$15K ﹤0.01% 948
2020
Q3 		$266K Buy
+10,369
New +$329K ﹤0.01% 910

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management's ETNB Position: Q2 2025 in Review

Jacobs Levy Equity Management sold out of 89bio (ETNB) in Q2 2025, closing a stake of 98,848 shares — an estimated $719K sold.

Jacobs Levy Equity Management first reported a position in ETNB in Q3 2020 and held it in 5 quarters. The position peaked at $969K in Q3 2024. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Jacobs Levy Equity Management reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 98,848 89bio shares in Q2 2025, an estimated $719K.
  • Jacobs Levy Equity Management first reported a position in 89bio in Q3 2020 and held it in 5 quarters.
  • Jacobs Levy Equity Management's 89bio position peaked at $969K in Q3 2024.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2025, filed 14 Aug 2025.